These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8329041)

  • 21. [Interference of digoxin-like immunoreactive substance in the analysis of digoxin in pulmonary pathology: preliminary results].
    Romano L; Zofra S; Imperato G; Adorno V; Maglione A
    Arch Monaldi; 1985; 40(3-4):157-64. PubMed ID: 3842060
    [No Abstract]   [Full Text] [Related]  

  • 22. Interference with digoxin immunoassays.
    Bottorff MB; Phelps SJ; Hoon TJ
    Clin Pharm; 1987 Feb; 6(2):100-2. PubMed ID: 3665365
    [No Abstract]   [Full Text] [Related]  

  • 23. Digoxin-like immunoreactivity in cord blood plasma extracts is not only due to endogenous corticosteroids.
    Yiannakou L; Loucari-Yiannakou E; Souvatzoglou A
    Clin Biochem; 1991 Dec; 24(6):475-82. PubMed ID: 1773487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radioimmunoassay of digoxin in serum using monoclonal antibodies and assessment of interference by digoxin-like immunoreactive substances.
    Loucari-Yiannakou E; Yiannakou L; Souvatzoglou A; Diamandis EP
    Ther Drug Monit; 1990 Mar; 12(2):195-200. PubMed ID: 2315977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of digoxin-like immunoreactive substance cross-reactivity with two digoxin immunoassays in normotensive third trimester pregnancy.
    Phelps S; Hammond K; Bottorff M; Sibai B
    Ther Drug Monit; 1987 Dec; 9(4):489. PubMed ID: 3424417
    [No Abstract]   [Full Text] [Related]  

  • 26. Cardiac glycosides.
    Koren G; Soldin SJ
    Clin Lab Med; 1987 Sep; 7(3):587-606. PubMed ID: 3308298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Digoxin-like material in liver disease].
    Shilo L; Shapiro MS; Shenkman L
    Harefuah; 1988 Mar; 114(5):224-5. PubMed ID: 3366400
    [No Abstract]   [Full Text] [Related]  

  • 28. Endogenous digoxin-like substances.
    J Pediatr; 1986 Nov; 109(5):910-1. PubMed ID: 3772672
    [No Abstract]   [Full Text] [Related]  

  • 29. Suspected DLIS interference in the dimension DGNA digoxin assay method and the clinical application of the revised digoxin target range.
    Morris RG; Jones TE; Goldsworthy SJ; Wagner TJ; Ho H; Horowitz JD
    Ther Drug Monit; 2006 Jun; 28(3):454-7. PubMed ID: 16778733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Digoxin radioimmunoassay that does not detect digoxin-like substance in serum of newborns, infants, or patients with renal failure.
    Witherspoon L; Shuler S; Neely H; Sonnemaker R; Alyea K; Gilbert S
    Clin Chem; 1987 Mar; 33(3):420. PubMed ID: 3815819
    [No Abstract]   [Full Text] [Related]  

  • 31. Influence of assay methodologies and interferences on the interpretation of digoxin concentrations.
    Fitzsimmons WE
    Drug Intell Clin Pharm; 1986; 20(7-8):538-42. PubMed ID: 3755675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comment: unusual digoxin concentrations.
    Mueller BA; Bussey HI; Casto DT
    DICP; 1989 Jan; 23(1):93-4. PubMed ID: 2718497
    [No Abstract]   [Full Text] [Related]  

  • 33. Digoxin-like immunoreactive substances in kidney- and liver-transplant patients.
    Dasgupta A; Dennen DA; Saldana S; Chou H; McLawhon RW
    Clin Chem; 1990 Jan; 36(1):171-2. PubMed ID: 2297924
    [No Abstract]   [Full Text] [Related]  

  • 34. [Interference of digoxin like immunoreactive substances with four recent reagents for digoxin determination].
    Marzullo C; Bourderont D; Dorr R
    Ann Biol Clin (Paris); 1996; 54(2):91-6. PubMed ID: 8763633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endogenous glycosides in critically ill patients.
    Berendes E; Cullen P; Van Aken H; Zidek W; Erren M; Hübschen M; Weber T; Wirtz S; Tepel M; Walter M
    Crit Care Med; 2003 May; 31(5):1331-7. PubMed ID: 12771599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Endogenous digitalis-like substance. II. Relation to pathologic states and diseases].
    Martinka E
    Vnitr Lek; 1995 Oct; 41(10):719-23. PubMed ID: 8578707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Digoxin-like immunoreactive substance in the elderly patient and its impact on the TDx digoxin assay.
    Yamamoto T; Takano K; Sanaka M; Nomura Y; Koike Y; Mineshita S
    Ther Drug Monit; 1998 Aug; 20(4):417-21. PubMed ID: 9712467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Falsely elevated serum digoxin levels secondary to endogenous digoxin-like immunoreactive substances.
    Koobatian TJ; Roberts JR
    Acad Emerg Med; 1995 Apr; 2(4):322-6. PubMed ID: 11727693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malignant immunoblastic lymphoma complicated by IgM gammopathy and digoxin-like immunoreactive substance.
    Ng JP; Green ST; McGovern E; Horn EM; Whiting B; Cumming RL; Hogg RB
    Clin Lab Haematol; 1987; 9(4):421-3. PubMed ID: 3442977
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of renal impairment on a new time-resolved fluoroimmunoassay for serum digoxin.
    Paterson NC; Stewart MJ
    Ann Clin Biochem; 1987 Mar; 24 ( Pt 2)():205-6. PubMed ID: 3592569
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.